NEW

Stock Screener with Intrinsic Value

×

Edwards Lifesciences Corporation (EW)

Last Price$69.8(0.1%)

Market Cap$41.7B

$5,872.6M

+0.9% YoY

$4,158.9M

+190.6% YoY

($3,739.4M)

Net Debt to FCF - (7.4x)

LTM Free Cash Flow (FCF)

$502.2M

8.6% margin

EW Income Statement

EW Income Statement Overview

Crunching data... Almost there!

EW Income statement key metrics

Crunching data... Almost there!

EW Balance Sheet

EW Balance Sheet Overview

Crunching data... Almost there!

EW Balance Sheet Metrics

Crunching data... Almost there!

EW Cash Flow Statement

EW Cash Flow Statement Overview

Crunching data... Almost there!

EW Cash Flow Statement key metrics

Crunching data... Almost there!

EW Financials

Crunching data... Almost there!

FAQ

What is the Edwards Lifesciences Corporation (EW) revenue?

The Edwards Lifesciences Corporation (EW) revenue is $6,004.8M, reflecting a year-over-year (YoY) growth of +11.6% YoY.

What is the Edwards Lifesciences Corporation (EW) Net Income?

The Edwards Lifesciences Corporation (EW) Net Income is $1,402.4M, showcasing a YoY growth of -7.9% YoY.

What is Edwards Lifesciences Corporation (EW) net debt?

The Edwards Lifesciences Corporation (EW) has a net debt of ($949.6M), with a Net Debt-to-Free Cash Flow (FCF) ratio of (1.5x).

What is the Edwards Lifesciences Corporation (EW) Free Cash Flow (FCF)?

The Edwards Lifesciences Corporation (EW) Free Cash Flow (FCF) stands at $629.5M, accounting for a 10.5% margin.